Coming out of Cornell Tech, Weill Cornell, and Columbia University, we are scientists, medical professionals, and health tech entrepreneurs pioneering the exploration of microbes from the human body, to the NYC subway, to hospitals, to outer space.
Biotia was founded by experts in metagenomics, software development, bioinformatics, and applied evolutionary biology.
Biotia was founded by experts in metagenomics, software development, bioinformatics, and applied evolutionary biology.
Location: United States, New York
Employees: 11-50
Total raised: $10.4M
Founded date: 2016
Investors 6
| Date | Name | Website |
| - | Third Act ... | thirdact.v... |
| 06.04.2023 | Phoenix Ve... | phoenix-vp... |
| - | Amplifyher... | amplifyher... |
| - | Everywhere... | everywhere... |
| - | Hyperplane... | hyperplane... |
| - | Red Bear A... | rbangels.c... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 30.08.2022 | Series A | $8M | OCA Ventur... |
| 10.12.2019 | Seed | $2.4M | - |
Mentions in press and media 11
| Date | Title | Description |
| 12.05.2023 | Biotia Launches GeoSeeq Watchtower System: A Global Genomics-Based Infectious Disease Monitoring Program | Any early warning system benefits from including genomics in combination with other data streams. NEW YORK (PRWEB) May 12, 2023 Biotia, a health tech company based in New York City, announced today its launch of the GeoSeeq Watchtower Syste... |
| 06.02.2023 | U.N. Hosts Climate and Health Scientists at Plenary on Vision of Future Pandemic Preparedness | Pathogens cross borders, so collaboration and data should also seamlessly move internationally between scientists, physicians and policymakers. NEW YORK (PRWEB) February 06, 2023 As part of the 77th session of the United Nations General Ass... |
| 19.11.2022 | Biotia and Partners Develop Tracking Platform to Help Prevent Public Health Crises | The COVID-19 pandemic has made it crystal clear that we need to prepare for health threats with real-time, global data that allows us to make informed decisions based on molecular data. MIAMI BEACH, Fla. (PRWEB) November 19, 2022 At the 7th... |
| 19.11.2022 | Biotia and Partners Develop Tracking Platform to Help Prevent Public Health Crises | Biotia launches technology platform to identify, analyze, track and forecast global health threats. MIAMI BEACH, Fla. (PRWEB) November 19, 2022 At the 7th Annual MetaSUB Conference, Biotia, Inc. announced that it is launching beta testing o... |
| 18.10.2022 | Biotia to Present Clinical Validation Data at IDWeek 2022 Annual Meeting | We are delighted that we were selected to present our clinical validation data and clinical-grade metagenomics tool that enables more accurate detection of pathogens in urine samples compared to culture. NEW YORK (PRWEB) October 18, 2022 Bi... |
| 24.08.2022 | Biotia Raises $8M to Fight Infectious Diseases Powered by AI & Genomics | What You Should Know: Biotia is a health tech company located in New York, NY, that leverages sequencing-based technology and proprietary AI-powered software to rapidly and accurately identify microorganisms and antimicrobial resistance. Th... |
| 23.08.2022 | Biotia, Pioneering Pathogen Detection Company, Raises an Oversubscribed $8M Series A | NEW YORK, NY / ACCESSWIRE / August 23, 2022 / Biotia, a company fighting infectious diseases powered by genomics and artificial intelligence (AI), has raised an oversubscribed $8 million Series A round led by OCA Ventures. OCA, a veteran ea... |
| 10.12.2019 | Biotia Raises $2.4M for AI-Powered Precision Infectious Disease Detection & Diagnosis | – Pioneering pathogen detection company Biotia raises $2.4M in seed funding to expand its scientific board and further develop and implement Biotia’s diagnostic testing methods, including its AI-based software platform. – Biotia has built o... |
| 10.12.2019 | Biotia, Pioneering Pathogen Detection Company, Raises $2.4M Seed Round, Expands Scientific Advisory Board | NEW YORK--(BUSINESS WIRE)--Biotia, a health tech company leveraging next-generation DNA sequencing (NGS) and artificial intelligence (AI) software for precision infectious disease detection and diagnosis, today announced an oversubscribed $... |
| 10.12.2019 | Biotia Raises $2.4M in Seed Funding | Biotia, a NYC-based health tech company, raised $2.4M in seed funding. The round was led by Falcon III Ventures, with participation from angel investors and venture capital firms including Hyperplane Venture Capital. The company intends to ... |
Show more